Your Claim After a Retraction: What Changes and What Doesn’t

The science said it was safe. Then the science was retracted.

Every day in the news, we hear about a “new study” that indicates that some chemical causes cancer. Or an everyday cosmetic product causes lung disease. Or a substance in our home, air, soil, or water causes long-term health effects. 

Toxic torts are civil lawsuits filed when a person seeks money for an injury or illness caused by contact with a dangerous chemical or toxic substance. These cases often involve companies that pollute the environment, sell defective products, or fail to warn people about known health dangers.

Often, we see a toxic tort lawsuit because a plaintiff used a product repeatedly, only to learn later that it caused their illness. Typically, a manufacturer is then sued because it becomes known that it was aware of the product’s dangers and continued to sell it, without adequate warning. 

You’ve probably heard of Glyphosate—the main chemical in the popular herbicide branded as Roundup—which was classified as a human carcinogen in 2015.

Several lawsuits followed the publication of the link between Glyphosate and cancer. It seemed well-settled that individuals who became ill after being exposed to Roundup could win lawsuits against Monsanto, the manufacturer. 

A 2000 paper published by the journal Elsevier established that Roundup is not harmful to humans. But in 2025, Elsevier journal Regulatory Toxicology and Pharmacology retracted the previous paper. The journal’s co-editor-in-chief pulled it over what he called “several critical issues that are considered to undermine the academic integrity of this article and its conclusions.” Specifically, they indicated that Monsanto employees helped write the paper without being named as authors, and that its conclusions leaned on a selective set of unpublished company studies while other long-term studies existed.

Four months later, in March 2026, The Lancet retracted an unsigned 1977 work that argued against government-mandated testing for asbestos in cosmetic talc. This came after numerous studies indicated that the presence of talc in cosmetics and baby products could cause cancer to humans. Researchers produced correspondence indicating that one of the authors sent Johnson & Johnson an advance draft and incorporated the company’s input before publication. The Lancet‘s editors wrote that this undisclosed relationship with J&J “was a clear breach of publishing ethics” and that, had the editors known at the time, “they would not have published this commentary.”

So, what does this mean for a plaintiff who has a pending lawsuit for a toxic tort? Let’s dig in.

What is a retraction of a scientific study?

A retraction is the scientific community’s formal statement that a paper should no longer be treated as part of the reliable record. It is not a court finding. It is not a determination that the product causes disease. It does not, by itself, prove causation in your case.

The retractions mentioned above were issued on ethical grounds—hidden authorship, undisclosed financial ties—not on demonstrating that the underlying data was false or fabricated. 

The distinction matters, and litigators in pending cases will dig into this concept with vigor. For instance, Monsanto’s parent company, Bayer, said the company’s contribution to the paper was disclosed in its acknowledgements. Further, it says regulators have independently concluded that glyphosate is not carcinogenic. Additionally, Johnson & Johnson said the Lancet article was based on “underhanded litigation tactics”—but these comments understate the changes that will happen because of these retractions.

What’s the result or effect of a science retraction?

• A load-bearing citation is gone. A defense expert will build causation out of a stack of literature. The 2000 Roundup study was cited 614 times; it was in the top 0.1 percent of most-cited glyphosate papers, and cites appeared in more than 700 academic and policy documents. When a paper that carries so much weight is withdrawn, every downstream document that relied on it becomes fair game for cross-examination. 
• The conduct, itself, becomes evidence. This is probably the bigger deal. Ghostwriting and concealed consulting arrangements are affirmative evidence of what the defendant company knew, and when. This points to notice, adequacy of warnings, fraudulent concealment, and punitive damages. This is about corporate behavior. 
• Regulatory-reliance defenses become more difficult. One of Monsanto’s arguments is that the EPA reviewed glyphosate and found it safe. But the EPA cited the 2000 paper in its 2016 glyphosate issue paper, its 2017 draft human health assessment, and its 2020 interim registration review decision. In other words, the agency relied on a now-withdrawn paper to issue safety guidance. This doesn’t erase the EPA’s conclusion, but it does call into question what the regulator was using to make its decision.

How do you proceed with a toxic tort lawsuit if the science is retracted?

Your lawsuit still requires the same elements of negligence as it always did: exposure, injury, general and specific causation, and a viable theory of liability. 

The retraction changes the strength and framing of evidence, but not the existence of the claim.

Monsanto Co. v. Durnell

June 25, 2026: Monsanto Co. v. Durnell (No. 24-1068), is a Supreme Court case in which the Court ruled 7-2 that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) expressly preempts state-law failure-to-warn claims against pesticide manufacturers.

This decision established that a state may not force a company to add cancer warnings to product labels like Roundup if it isn’t mandated by the Environmental Protection Agency (EPA).

Missouri farmer John Durnell developed non-Hodgkin’s lymphoma (a form of cancer) after using Roundup for about 20 years. He sued Monsanto in state court, arguing that Monsanto failed to warn consumers about the potential cancer risks. A Missouri jury awarded Durnell more than $1 million, and the decision was later affirmed by the Missouri Court of Appeals. However, the U.S. Supreme Court reversed the lower court judgment. 

According to the Court’s decision, FIFRA requires national uniformity for pesticide labeling and blocks states from imposing requirements “in addition to or different from” federal rules. Since the EPA consistently concluded that glyphosate is not likely to cause cancer and did not approve a cancer warning. A state tort law may not mandate a labeling requirement that conflicts with EPA guidance. 

How might this affect your lawsuit?

If you have a Roundup claim that’s based on failure to warn, then your theory of liability is now in jeopardy in federal and most state courts. 

Your attorney might choose to instead establish a new strategy that would shift to one of the following:

• A design defect (which would be the formulation, itself, including surfactants and adjuvants—not the label); 
• Negligent testing; 
• Fraud, misrepresentation, and concealment claims; or 
• Consumer protection and advertising claims based on marketing representations, rather than label warnings; and claims involving risks never affirmatively considered by the EPA.

In these strategies, the retracted paper would be useful because it speaks to what the company did, and not what the label said.

How many cases are affected by retracted science?

There is no registry that tracks lawsuits affected by retracted science. 

The only way to estimate is by investigating specific issues. 

Monsanto estimated that there were about 61,000 active claims, as of June 2026. This is after the company settled nearly 100,000 claims for approximately $11 billion, with a proposed nationwide class settlement announced in February 2026. 

For the talc lawsuits, there were 68,435 cases pending in MDL-2738 (multi-district litigation, which is similar to a class action lawsuit) in July 2026. This makes it the largest MDL in the federal system; more than 67,000 plaintiffs have filed lawsuits since 2009. On July 27, 2026, Johnson & Johnson announced a proposed $5.5 billion resolution of the ovarian cancer talc litigation. It would cover about 76,000 claims, on the condition that at least 95 percent of the remaining claimants would participate, and that the first payment would be no more than $3 billion in 2027. 

Combined (though unrelated), these are 130,000 pending claims in litigation where retracted papers have been part of the defense strategy. This matters as we watch legal trends: There are now more than 66,000 retractions catalogued in the Retraction Watch Database; there were more than 10,000 retraction notices in a single year for the first time in 2023. 

And yet… Most citations to retracted papers never mention the retraction. There are papers that shaped a product’s safety reputation 20 or 40 years ago that are still cited today, even if they were eventually retracted.

How can you strengthen your claim?

1. Focus your documents. Gather the items you can supply. Clients often under-document proof of exposure, and this is what often decides the case. This could include purchase records, product photos, empty containers, employment and application records, brand and formulation specifics, and dates and duration of use. A timeline written in your own words, dated, and with names of people who saw you use the product, is worth more than a published journal article. 
2. Have complete medical records. Make sure your attorney has complete pathology reports—not just discharge summaries—along with the specific diagnosis and subtype, and a full record of other potential exposures. The defense will look for alternative causes, so this is important. 
3. Know your science. You don’t need to go out and get a PhD, but you can review the Retraction Watch Database (a nonprofit organization) and PubMed, which flags retracted articles. If a defense filing, settlement letter, or news article cites a study you can’t verify, send it to your lawyer (don’t draw your own conclusions).

What to ask your lawyer about a retracted science paper related to your lawsuit

• Do my claims survive Durnell (if they’re Roundup claims), and are we leading with a different theory, now?
• Does the retraction affect my case as causation evidence, conduct evidence for punitive damages, or both? 
• Do our experts rely on something that was retracted or corrected? Have we checked the defense experts’ materials the same way? 
• How does the retraction interact with the pending settlement program? Does it change whether I should continue to participate or opt out? 
• Does this affect my filing deadline?

If you’re raising your eyebrows at the last question, here’s how deadlines could change: A retraction typically doesn’t restart a statute of limitations. However, waiting for more science to develop is one of the most common ways a valid claim is lost. If you’ve not yet filed your claim, talk with your lawyer about analyzing the deadline. 

Science retractions like these rarely win a case on their own. But they do take a brick out of the defense’s wall, and hand your side a document trail about corporate conduct. Sometimes, this is the more valuable outcome in mass tort litigation.